Loading…
Based on limited metadata from an FDA Warning Letter issued to H-Lab Life on August 7, 2020, the agency identified compliance concerns related to drug products manufactured or distributed by the company. While the specific violations cannot be detailed without access to the full letter text, the warning falls under FDA's drug regulatory authority. To understand the precise nature of the violations and required corrective actions, the complete Warning Letter would need to be reviewed.